NSAIDs is one of 212 small molecule programs targeting Low back pain. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
176 competitors in Rheumatoid Arthritis
NSAIDs
Actos
Voltaren
Cataflam
Plaquenil
Vibramycin
Velcade
Solu-Medrol
Decadron
Valium
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources